Comments
Loading...
Agenus (NASDAQ:AGEN) Stock Quotes, Forecast and News Summary
Agenus Stock (NASDAQ: AGEN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Agenus (AGEN) stock?
You can purchase shares of Agenus (NASDAQ:AGEN) through any online brokerage.
Who are Agenus (AGEN) competitors?
Other companies in Agenus’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), OncoCyte (NASDAQ:OCX), Inozyme Pharma (NASDAQ:INZY), Aligos Therapeutics (NASDAQ:ALGS) and FibroGen (NASDAQ:FGEN).
What is the forecast, or price target, for Agenus (AGEN) stock?
Agenus has a consensus price target of $10.23.
What is the current price for Agenus (AGEN)?
The stock price for Agenus (NASDAQ: AGEN) is $3.39 last updated February 21, 2025 at 10:36 AM EST.
Does Agenus (AGEN) pay a dividend?
There are no upcoming dividends for Agenus.
When is Agenus (NASDAQ:AGEN) reporting earnings?
Agenus’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Agenus (AGEN) going to split?
There is no upcoming split for Agenus.
What sector and industry does Agenus (AGEN) operate in?
Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.